FDA-Inspected Site

Edge Biologicals Inc

9 FDA inspections are on record for Edge Biologicals Inc in Memphis, United States.

Clean· No action indicated

Memphis, United States · Last updated July 10, 2026

Overview

  • 9 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-01-08.

At a glance

Inspections

9

Form 483s

5

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Jan 2026 – 8 Jan 2026Medical Devices & Rad HealthClean
18 Nov 2024 – 22 Nov 2024Medical Devices & Rad Health483View 483 →
20 Mar 2023 – 4 Apr 2023Medical Devices & Rad HealthWLView 483 →
12 Mar 2018 – 15 Mar 2018Medical Devices & Rad Health483View 483 →
26 Jan 2015 – 29 Jan 2015Medical Devices & Rad Health483View 483 →
16 Sep 2011Not recordedWLView 483 →
2 Feb 2007Not recordedClean
1 Mar 2002Not recordedClean
18 May 2001Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

22 Nov 2024
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Jamie P Webb

22 Nov 2024
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Jamie P Webb

22 Nov 2024
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Jamie P Webb

22 Nov 2024
21 CFR 820.80(d)

Lack of or inadequate final acceptance procedures

Cited by Jamie P Webb

4 Apr 2023
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Javelle P Spann

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.75(a)Cited across public-safe Form 483 observations6x
21 CFR 820.198(a)Cited across public-safe Form 483 observations5x
21 CFR 820.100(a)Cited across public-safe Form 483 observations4x
21 CFR 820.70(c)Cited across public-safe Form 483 observations4x
21 CFR 820.181Cited across public-safe Form 483 observations3x
21 CFR 820.22Cited across public-safe Form 483 observations3x
21 CFR 820.50(a)Cited across public-safe Form 483 observations3x
21 CFR 820.90(a)Cited across public-safe Form 483 observations3x
21 CFR 820.100(b)Cited across public-safe Form 483 observations2x
21 CFR 820.120Cited across public-safe Form 483 observations2x
21 CFR 820.184Cited across public-safe Form 483 observations2x
21 CFR 820.20(c)Cited across public-safe Form 483 observations2x
21 CFR 820.25(b)Cited across public-safe Form 483 observations2x
21 CFR 820.30(g)Cited across public-safe Form 483 observations2x
21 CFR 820.30(j)Cited across public-safe Form 483 observations2x
21 CFR 820.70(g)(1)Cited across public-safe Form 483 observations2x
21 CFR 820.75(b)Cited across public-safe Form 483 observations2x
21 CFR 803.17Cited across public-safe Form 483 observations1x
21 CFR 803.17(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.130Cited across public-safe Form 483 observations1x
21 CFR 820.25(a)Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.70(b)Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.80(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(d)Cited across public-safe Form 483 observations1x
21 CFR 820.86Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Edge Biologicals Inc's 5 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat